Xeris Pharmaceuticals Inc (XERS) — Working Capital to Net Assets Ratio
Xeris Pharmaceuticals Inc (XERS) has a Working Capital to Net Assets ratio of -875.2% as of June 2026. Working capital of $85.19 Million (current assets of $274.76 Million minus current liabilities of $189.57 Million) is measured against net assets of $-9.73 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. For the complete balance sheet picture, see Xeris Pharmaceuticals Inc asset portfolio.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Xeris Pharmaceuticals Inc Working Capital to Net Assets (2016–2025)
This chart shows how Xeris Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at -875.2%, reflecting working capital of $85.19 Million against net assets of $-9.73 Million USD. Explore XERS capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Working Capital to Net Assets for Xeris Pharmaceuticals Inc (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Xeris Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Explore XERS long-term investments to assets to see how much of total assets are deployed in long-term investments.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 955.1% | $130.74 Million | $13.69 Million | $240.31 Million | $109.57 Million | ▲ +1182.0 pp |
| 2024 | -227.0% | $67.22 Million | $-29.61 Million | $167.66 Million | $100.44 Million | ▲ +673.5 pp |
| 2023 | -900.5% | $61.07 Million | $-6.78 Million | $156.26 Million | $95.19 Million | ▼ -1151.0 pp |
| 2022 | 250.5% | $113.20 Million | $45.19 Million | $186.82 Million | $73.62 Million | ▲ +183.8 pp |
| 2021 | 66.7% | $63.56 Million | $95.23 Million | $142.60 Million | $79.04 Million | ▼ -349.9 pp |
| 2020 | 416.6% | $60.15 Million | $14.44 Million | $87.48 Million | $27.34 Million | ▲ +0.0 pp |
| 2019 | 416.6% | $60.15 Million | $14.44 Million | $87.48 Million | $27.34 Million | ▲ +273.8 pp |
| 2018 | 142.9% | $107.73 Million | $75.41 Million | $117.90 Million | $10.17 Million | ▲ +210.6 pp |
| 2017 | -67.8% | $39.19 Million | $-57.83 Million | $44.05 Million | $4.86 Million | ▲ +28.2 pp |
| 2016 | -96.0% | $30.65 Million | $-31.93 Million | $33.17 Million | $2.53 Million | — |